ClinicalTrials.Veeva

Menu

Oral Carbohydrate in DM Patients Undergoing Total Knee Arthroplasty

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Total Knee Arthroplasty

Treatments

Dietary Supplement: 10% dextrose solution mixed with insulin 16 unit 100 mL/h
Dietary Supplement: Carbohydrate-rich drink

Study type

Interventional

Funder types

Other

Identifiers

NCT02432781
4-2015-0151

Details and patient eligibility

About

The primary purpose of this study is to investigate the effects of carbohydrate-rich drink on postoperative nausea and vomiting in diabetic patients undergoing total knee arthroplasty. The secondary purpose is to investigate the effects of carbohydrate-rich drink on quality of recovery and inflammation in diabetic patients after total knee arthroplasty.

Full description

Carbohydrate-rich drink has been proved to neither delay gastric emptying nor affect gastric acidity and is therefore considered safe to use in elective surgical patients without risk factors for pulmonary aspiration. It reduced postoperative nausea and vomiting and improved sense of well-being after surgery. Moreover, carbohydrate-rich drink was not found to be affected by delayed gastric emptying in patients with uncomplicated type 2 diabetes. Therefore, carbohydrate drink may be safely administered 3 h before anesthesia without risk of hyperglycemia or aspiration.

Enrollment

82 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type 2 DM patients undergoing elective total knee arthroplasty

Exclusion criteria

  • Contraindication to regional anesthesia
  • Patients whose operation is scheduled to start after 9:00 am
  • Dementia or cognitive dysfunction
  • HbA1c > 8%
  • Gastroesophageal reflux disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

82 participants in 2 patient groups

Carbohydrate group
Experimental group
Description:
Carbohydrate-rich drink 400 mL 3 h before surgery
Treatment:
Dietary Supplement: Carbohydrate-rich drink
Control group
Active Comparator group
Description:
10% dextrose solution mixed with insulin 16 unit 100 mL/h
Treatment:
Dietary Supplement: 10% dextrose solution mixed with insulin 16 unit 100 mL/h

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems